Overview

Xenon Inhalation for Treatment of Panic Disorder

Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This study is a double-blind, randomized, placebo-controlled, clinical trial in parallel groups in patients with panic disorder.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Nobilis Therapeutics Inc.
Treatments:
Xenon